First, Alter admits the “best” available studies are from the Guttmacher Institute, a pro-abortion organization that was founded as a division of Planned Parenthood. No conflict of interest there.
Second, Alter falsely assumes the 600,000 women a year who get birth control from Planned Parenthood wouldn’t have anywhere else to get birth control. He then falsely assumes Planned Parenthood is the reason 600,000 women a year end up not getting pregnant. He completes his argument with the ridiculous claim that Planned Parenthood prevents a few hundred thousand abortions a year, a claim based on his own false assumptions. You’re a gem, Alter.
On Friday, a court in Illinois is set to hear motions regarding a battery lawsuit against the Hope Clinic for Women abortion clinic.
Plaintiff Brandy Hildreth is seeking damages in excess of $1.4 million and other relief in the suit.
Hope Clinic for Women, its director Sally Burgess, staffers Clara Dixon, Debra Weihardt, Anne Baker, Denise Caldwell, Dr. Allen Palmer, Dr. Melissa Gilliam, Dr. Lisa Memmel and the University of Chicago Medical Center are all named as defendants in the suit.
Hildreth claims she was battered by Memmel and misled by the clinic staff as to whom would perform her 2008 abortion. That misrepresentation, she alleges, caused her emotional distress.
Hylla is set to hear motions in the case at 9:30 a.m. Friday.
Memmel and several of the other defendants in the suit have filed motions asking for summary judgment in the suit.
In those moves, the defendants contend that Hildreth was aware that Memmel, a graduate student in a program through the Chicago medical center, would perform the procedure and that she did not object to Memmel performing the abortion.
A study by Greek researchers found that adult stem cells can help prevent multiple sclerosis (MS) from progressing.
An average of 11 years after their transplants, 25% of the patients in Greece have not seen their disease progress, the researchers report.
Among patients with active lesions on MRI scans before their transplants, indicating that they were in an inflammatory phase of the disease, 44% have not progressed.
Only 10% of patients who went into the study without evidence of ongoing inflammation were able to remain disease free.
Two patients died from transplant-related complications.